Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway
about
Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.The spike protein of SARS-CoV--a target for vaccine and therapeutic development.Inhibition of Ebola virus entry by a C-peptide targeted to endosomes.Incorporation of spike and membrane glycoproteins into coronavirus virions.Potential vaccines and post-exposure treatments for filovirus infections.Entry from the cell surface of severe acute respiratory syndrome coronavirus with cleaved S protein as revealed by pseudotype virus bearing cleaved S protein.Protease-mediated entry via the endosome of human coronavirus 229E.Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sitesCell-based antiviral screening against coronaviruses: developing virus-specific and broad-spectrum inhibitorsThe contribution of the cytoplasmic retrieval signal of severe acute respiratory syndrome coronavirus to intracellular accumulation of S proteins and incorporation of S protein into virus-like particles.Influence of hydrophobic and electrostatic residues on SARS-coronavirus S2 protein stability: insights into mechanisms of general viral fusion and inhibitor design.
P2860
Q30432156-9F7EF073-DDD9-43FC-AB1F-0F827BF0967FQ34015988-CCF72120-CB71-4B94-9299-1428E151C2F4Q34963154-F9D6CDD2-B7F1-47B6-96C9-869B2F443D05Q35544383-AD079E60-DBBA-4527-BAB1-6E9EF19837F9Q36404178-DCC85424-486D-4574-80D3-299E465B32ADQ36974675-F89F2694-6BC8-4B52-A051-AE09EC99BD53Q37033358-C661BB7E-BDEA-44D3-AA96-C468D0FA2FA7Q37138587-FC338EF6-7FD0-4678-8089-6BC9C63381BCQ37596746-649C0060-3CD2-46C2-A7BE-1BC97462F67FQ38773205-B221FF01-193A-47C5-9574-61F32D440B7FQ39095556-67ECA82E-7AE9-4671-B6F6-083B15BC4CAF
P2860
Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Heptad repeat-derived peptides ...... ntry via the endosomal pathway
@ast
Heptad repeat-derived peptides ...... ntry via the endosomal pathway
@en
type
label
Heptad repeat-derived peptides ...... ntry via the endosomal pathway
@ast
Heptad repeat-derived peptides ...... ntry via the endosomal pathway
@en
prefLabel
Heptad repeat-derived peptides ...... ntry via the endosomal pathway
@ast
Heptad repeat-derived peptides ...... ntry via the endosomal pathway
@en
P2093
P2860
P50
P356
P1433
P1476
Heptad repeat-derived peptides ...... ntry via the endosomal pathway
@en
P2093
Akira Otaka
Fumihiro Taguchi
Hiroki Nishikawa
Makoto Ujike
Nobutaka Fujii
Norio Yamamoto
P2860
P304
P356
10.1128/JVI.01697-07
P407
P577
2007-10-17T00:00:00Z